V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20160942 | 20062129 | 1.69 | 62 | Palliative (P) | 2016-07-07 | 2016-07-15 | ECX | N | null | ECX | 100392682 |
| 20160947 | 20062130 | 1.68 | 63.7 | Palliative (P) | 2017-10-26 | 2017-11-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100193149 |
| 20160949 | 20062131 | 1.75 | 65.2 | null | 2016-09-08 | 2016-09-15 | Gemcitabine + Capecitabine | N | N | ECX | 100414532 |
| 20160950 | 20062132 | 1.64 | 107.8 | Adjuvant (A) | 2018-02-03 | 2018-02-03 | CAPECITABINE + GEMCITABINE | 2 | null | CAPECITABINE + GEMCITABINE | 101181859 |
| 20160951 | 20062133 | 1.66 | 62 | Curative (C) | 2016-06-23 | 2016-06-24 | ECX | N | N | ECX | 101035439 |
| 20160952 | 20062134 | 1.7 | 78.8 | Palliative (P) | 2017-07-26 | 2017-08-08 | ECX | N | Y | ECX | 100212426 |
| 20160954 | 20062135 | 1.65 | 80 | Adjuvant (A) | 2017-07-10 | 2017-07-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101520217 |
| 20160956 | 20062136 | 1.76 | 92 | Neo-adjuvant (N) | 2018-05-31 | 2018-06-24 | ECX | N | Y | ECX | 101362986 |
| 20160957 | 20062137 | 1.77 | 68.4 | Neo-adjuvant (N) | 2018-03-08 | 2018-03-15 | ECX | 02 | N | ECX | 100301245 |
| 20160959 | 20062138 | 1.86 | 67 | Palliative (P) | 2017-06-11 | 2017-06-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100988653 |
| 20160964 | 20062139 | null | null | Adjuvant (A) | 2016-12-06 | 2016-12-12 | ECX | N | N | ECX | 100644085 |
| 20160965 | 20062140 | 1.75 | 80.4 | Neo-adjuvant (N) | 2019-10-23 | 2019-10-24 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101437016 |
| 20160966 | 20062141 | 1.72 | 62.9 | Palliative (P) | 2017-08-12 | 2017-08-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100678637 |
| 20160967 | 20062142 | 1.8 | 79 | Adjuvant (A) | 2018-03-15 | 2018-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100005625 |
| 20160968 | 20062143 | 1.7 | 79 | Adjuvant (A) | null | 2017-10-28 | ECX | N | null | ECX | 100813783 |
| 20160969 | 20062144 | 1.65 | 120 | Curative (C) | 2019-01-24 | 2019-02-06 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100644596 |
| 20160976 | 20062145 | 1.67 | 127.3 | Adjuvant (A) | 2018-02-11 | 2018-02-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101154584 |
| 20160977 | 20062146 | 1.62 | 87.45 | Palliative (P) | 2019-11-02 | 2019-11-16 | ECX | N | N | ECX | 101097885 |
| 20160978 | 20062147 | 1.72 | 57.3 | Neo-adjuvant (N) | 2018-01-15 | 2018-01-23 | ECX | 02 | N | ECX | 100657451 |
| 20160980 | 20062148 | 1.85 | 57.3 | Adjuvant (A) | 2018-12-23 | 2018-12-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101236542 |
| 20160982 | 20062149 | 1.57 | 59 | Adjuvant (A) | 2019-10-14 | 2019-10-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100151707 |
| 20160984 | 20062150 | 1.62 | 74.8 | Palliative (P) | 2016-07-14 | 2016-07-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101429296 |
| 20160985 | 20062151 | 1.81 | 95.6 | null | 2019-06-01 | 2019-06-02 | ECX | N | N | ECX | 101051307 |
| 20160988 | 20062152 | 1.7 | 73.5 | Neo-adjuvant (N) | 2016-07-22 | 2016-07-31 | ECX | 02 | N | ECX | 100702990 |
| 20160989 | 20062153 | 1.83 | 72 | Adjuvant (A) | 2019-08-13 | 2019-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101682256 |
| 20160991 | 20062154 | 1.73 | 99.3 | Disease modification (D) | 2019-05-16 | 2019-05-21 | Gemcitabine + Capecitabine | 2 | N | ECX | 100517064 |
| 20160993 | 20062155 | 1.68 | 55 | null | 2019-03-09 | 2019-04-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100405985 |
| 20160995 | 20062156 | 1.67 | 58.4 | Neo-adjuvant (N) | 2018-01-15 | 2018-01-28 | ECX | 02 | N | ECX | 100067571 |
| 20160996 | 20062157 | 1.85 | 87 | Palliative (P) | null | 2019-02-26 | ECX | null | N | ECX | 100956581 |
| 20161000 | 20062158 | null | null | Neo-adjuvant (N) | 2017-06-16 | 2017-06-22 | ECX | 02 | N | ECX | 100012408 |
| 20161002 | 20062159 | 1.63 | 81.8 | Neo-adjuvant (N) | 2017-10-23 | 2017-11-05 | ECX | 02 | null | ECX | 100731736 |
| 20161003 | 20062160 | 1.87 | 70.15 | Palliative (P) | 2017-03-08 | 2017-03-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101058413 |
| 20161004 | 20062161 | 1.67 | 77 | Neo-adjuvant (N) | 2019-12-12 | 2019-12-15 | ECX | 02 | N | ECX | 101867336 |
| 20161005 | 20062162 | 1.74 | 71.6 | Palliative (P) | 2017-08-17 | 2017-08-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100281288 |
| 20161008 | 20062163 | 1.88 | 48.3 | Adjuvant (A) | 2020-02-26 | 2020-02-26 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101822753 |
| 20161009 | 20062164 | 1.84 | 58.9 | Palliative (P) | 2020-01-05 | 2020-01-18 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101759379 |
| 20161010 | 20062165 | 1.72 | 101.2 | Curative (C) | 2018-10-31 | 2018-10-31 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100243890 |
| 20161011 | 20062166 | 1.67 | 125.15 | Adjuvant (A) | 2018-09-02 | 2018-09-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101381243 |
| 20161012 | 20062167 | null | 43.4 | Curative (C) | 2017-05-14 | 2017-05-21 | ECX | null | N | CAPECITABINE + GEMCITABINE | 101489274 |
| 20161013 | 20062168 | 1.73 | 68.7 | Neo-adjuvant (N) | 2017-10-21 | 2017-10-26 | ECX | N | N | ECX | 100444248 |
| 20161014 | 20062169 | 1.6 | 53.9 | Palliative (P) | null | 2019-01-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100951972 |
| 20161015 | 20062170 | 1.69 | 100.5 | Neo-adjuvant (N) | 2018-03-08 | 2018-03-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101021447 |
| 20161018 | 20062171 | 1.72 | 66.1 | null | 2017-04-12 | 2017-04-12 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100301278 |
| 20161019 | 20062172 | 1.71 | 53 | Adjuvant (A) | 2019-05-13 | 2019-05-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100880811 |
| 20161023 | 20062173 | 1.77 | 81 | Neo-adjuvant (N) | 2017-07-13 | 2017-08-02 | ECX | 02 | N | ECX | 101145483 |
| 20161025 | 20062174 | 1.69 | 77.9 | Neo-adjuvant (N) | 2019-09-18 | 2019-10-03 | ECX | N | N | ECX | 101840761 |
| 20161026 | 20062175 | 1.74 | 90 | Neo-adjuvant (N) | 2016-09-23 | 2016-10-06 | ECX | N | N | ECX | 101682756 |
| 20161030 | 20062176 | 1.59 | 87 | null | null | 2016-11-10 | ECX | null | N | ECX | 100082023 |
| 20161031 | 20062177 | 1.61 | 65.8 | Adjuvant (A) | 2016-11-15 | 2016-12-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100223156 |
| 20161035 | 20062178 | 1.76 | 82.8 | Neo-adjuvant (N) | 2018-10-04 | 2018-10-18 | ECX | N | N | ECX | 101124835 |